Patent details

Basic Information

Publication number:

EP1268453

PCT Application Number:

PCT/IB/2001/000427

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP019120690

PCT Publication Number:

WO/2001/077093

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ESTROGEN AGONIST/ANTAGONIST METABOLITES

French Title of Invention:

METABOLITES AGONISTES/ANTAGONISTES D'OESTROGENE

German Title of Invention:

METABOLITE VON ESTROGEN-AGONISTEN/-ANTAGONISTEN

SPC Number:

Dates

Filing date:

19/03/2001

Grant date:

19/07/2006

EP Publication Date:

19/07/2006

PCT Publication Date:

18/10/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/01/2003

EP B1 Publication Date:

19/07/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

19/03/2007

Expiration date:

19/03/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/03/2001

 

 

Name:

Pfizer Products Inc.

Address:

Eastern Point Road, Groton, Connecticut 06340, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

26/07/2006

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

DAY W. W. Pfizer Global Res. & Development

Address:

United States (US)

2

Name:

EGGLER J. F. Pfizer Global Res. & Development

Address:

United States (US)

3

Name:

PRAKASH C. A. Pfizer Global Res. & Development

Address:

United States (US)

4

Name:

JOHNSON K. A. Pfizer Global Res. & Development

Address:

United States (US)

Priority

Priority Number:

267198 P

Priority Date:

07/04/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 295/08;

Filing date	Document type	Number of pages